Multimodality treatment of malignant pleural mesothelioma

Malignant pleural mesothelioma (MPM) is a rare disease of the pleura and is largely related to asbestos exposure. Despite recent advancements in technologies and a greater understanding of the disease, the prognosis of MPM remains poor; the median overall survival rate is about 6 to 9 months in untr...

Descripción completa

Detalles Bibliográficos
Autores principales: Berzenji, Lawek, Van Schil, Paul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000 Research Limited 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198256/
https://www.ncbi.nlm.nih.gov/pubmed/30410726
http://dx.doi.org/10.12688/f1000research.15796.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6198256/
https://www.ncbi.nlm.nih.gov/pubmed/30410726
http://dx.doi.org/10.12688/f1000research.15796.1

Ejemplares similares